Market Place
Sourcing Support
AstraZeneca unit sued over alleged monopoly on drug Soliris
17 Apr 2025 //
REUTERS
AstraZeneca Pharma India surrenders Olaparib marketing authorizat
16 Apr 2025 //
INDPHARMAPOST
EU pharma firms demand to stay in EU amid expected US tariffs
15 Apr 2025 //
REUTERS
AstraZeneca highlights infectious disease protection at ESCMID 2025
10 Apr 2025 //
INDPHARMAPOST
Datroway® EU approval for metastatic HR+, HER2- breast cancer.
08 Apr 2025 //
BUSINESSWIRE
Enhertu Approved in EU as First HER2 Therapy for HR+ Breast Cancer
05 Apr 2025 //
BUSINESSWIRE
Inka Health Completes Analytics for AstraZeneca Canada
03 Apr 2025 //
ACCESSWIRE
AstraZeneca Pharma India, Pharmaids, Dr. Agarwal`s in Briefs
01 Apr 2025 //
INDPHARMAPOST
AZ`s oral PCSK9 inhibitor halves bad cholesterol in phase 2
01 Apr 2025 //
FIERCE BIOTECH
AZ, MSK adopt tech firm`s data capture tool for phase 3 trial
01 Apr 2025 //
FIERCE BIOTECH
ENHERTU® Phase 3 Trial Begins for HER2+ Advanced Gastric Cancer
01 Apr 2025 //
BUSINESSWIRE
AZ`s Imfinzi wins perioperative FDA nod in bladder cancer
01 Apr 2025 //
FIERCE PHARMA
AZD0780, oral inhibitor, reduces LDL-C in PURSUIT Phase IIb Trial
31 Mar 2025 //
BUSINESSWIRE
TAGRISSO® reaffirmed as key therapy for EGFR-mutated lung cancer
25 Mar 2025 //
BUSINESSWIRE
Syneron Bio Announces Strategic Collaboration with AstraZeneca
24 Mar 2025 //
PR NEWSWIRE
AstraZeneca investing $2.5 B in China
22 Mar 2025 //
REUTERS
AstraZeneca signs Alteogen deal worth up to $1.35B
19 Mar 2025 //
FIERCE PHARMA
AstraZeneca`s $800M rare disease bet hits primary Ph 3 goal
17 Mar 2025 //
FIERCE BIOTECH
AstraZeneca boosts cancer therapies with $1B EsoBiotec buy
17 Mar 2025 //
REUTERS
AstraZeneca and Erin Andrews inspire fans to Get Body Checked
14 Mar 2025 //
BUSINESSWIRE
AstraZeneca approved to sell hyperkalaemia treatment in India
08 Mar 2025 //
ECONOMICTIMES
Imfinzi Shows EFS Benefit In Early Gastric, GEJ Cancers
07 Mar 2025 //
BUSINESSWIRE
AstraZeneca gets CDSCO approval to import, sell cancer medicine
04 Mar 2025 //
ECONOMICTIMES
Astrazeneca India Gets CDSCO Nod To Import, Sell Cancer Drug
03 Mar 2025 //
ECONOMICTIMES
Tezspire Treats Chronic Sinus Symptoms With Nasal Polyps
03 Mar 2025 //
PR NEWSWIRE
EU Backs AstraZeneca-Daiichi’s Enhertu for Breast Cancer
01 Mar 2025 //
REUTERS
CHMP Recommends ENHERTU For HER2 Low/Ultralow Metastatic Breast Cancer
28 Feb 2025 //
BUSINESSWIRE
AstraZeneca Posts Positive Ph 3 Results for Oral Breast Cancer Drug
27 Feb 2025 //
PRESS RELEASE
TFS HealthScience Announces Leadership Transition: Katarina Agebo
24 Feb 2025 //
PR NEWSWIRE
AstraZeneca boosts China presence with FibroGen`s anemia drug in $160M deal
21 Feb 2025 //
REUTERS
FibroGen Sells China Business To AstraZeneca For $160M
20 Feb 2025 //
GLOBENEWSWIRE
Astrazeneca Pharma India Net Profit Rises 95.25% In Q3
12 Feb 2025 //
BUSINESS STD
Astrazeneca Pharma gains after Q3 PAT soars to Rs 55 cr
12 Feb 2025 //
BUSINESS STD
AZ’s Alexion creates interactive storybook for kids with aHUS
12 Feb 2025 //
FIERCE PHARMA
AIM Plans Study Of Ampligen® & FluMist® For Avian Influenza
07 Feb 2025 //
GLOBENEWSWIRE
AstraZeneca CEO defends `fantastic` Alexion buy as halts drug
07 Feb 2025 //
FIERCE BIOTECH
AstraZeneca shares rise as China probe update reassures
07 Feb 2025 //
REUTERS
AstraZeneca`s Full Year and Q4 2024 results
06 Feb 2025 //
BUSINESSWIRE
AstraZeneca shareholders say need clarity on China investigations
05 Feb 2025 //
REUTERS
Erasmus Safety Committee Approves Ph 2 Study for Pancreatic Cancer
05 Feb 2025 //
GLOBENEWSWIRE
UK hits back at AstraZeneca over collapse of investment deal
04 Feb 2025 //
REUTERS
AZ scraps £450M vaccine plant expansion in the UK
01 Feb 2025 //
FIERCE PHARMA
AstraZeneca ditches UK investment over cut in state support
31 Jan 2025 //
REUTERS
Datopotamab Deruxtecan Recommended For Approval In EU By CHMP
31 Jan 2025 //
BUSINESSWIRE
Tropion-Lung12 Phase 3 Trial Begins For Datroway In NSCLC
30 Jan 2025 //
BUSINESSWIRE
Roche`s Itovebi pads its case with overall survival win
28 Jan 2025 //
REUTERS
Enhertu Approved in US for HER2-Low/Ultralow Breast Cancer
27 Jan 2025 //
BUSINESSWIRE
AstraZeneca Canadian investment to drive R&D growth
24 Jan 2025 //
EUROPEAN PHARMACEUTICAL REVIEW
AstraZeneca receives recommendations for lung cancer treatments
22 Jan 2025 //
PHARMATIMES
FDA Approves Acalabrutinib for Mantle Cell Lymphoma
17 Jan 2025 //
PRESS RELEASE
CDSCO approves AstraZeneca’s anti-complement medicine
17 Jan 2025 //
EXPRESSPHARMA
Datopotamab Deruxtecan Gets Priority Review For NSCLC Treatment
13 Jan 2025 //
BUSINESSWIRE
Synthego & AstraZeneca Sign CRISPR Gene Editing Enzyme Deal
13 Jan 2025 //
CONTRACTPHARMA
J&J`s combo extend patient` lives in study with AstraZeneca`s drug
08 Jan 2025 //
FIERCE PHARMA
Hutchmed`s Priority Review For Orpathys-Tagrisso In Lung Cancer
01 Jan 2025 //
GLOBENEWSWIRE
AstraZeneca India recasts biopharma unit
30 Dec 2024 //
ECONOMICTIMES
Volumes spurt at Astrazeneca Pharma India Ltd counter
30 Dec 2024 //
BUSINESS STD
What can AZ`s China probes teach other biopharma companies?
28 Dec 2024 //
FIERCE PHARMA
Datopotamab Deruxtecan Application in EU is Voluntarily Withdrawn
26 Dec 2024 //
BUSINESSWIRE
Achilles Announces Sale of Technology Assets to AstraZeneca
26 Dec 2024 //
GLOBENEWSWIRE
